XWELL Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

XWELL heeft een totaal eigen vermogen van $17.2M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $36.3M en $19.1M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsratio	n/a
Contant	US$18.38m
Aandelen	US$17.23m
Totaal verplichtingen	US$19.06m
Totaal activa	US$36.29m

Recente financiële gezondheidsupdates

XWELL (NASDAQ:XWEL) Will Have To Spend Its Cash Wisely

Jul 14

Recent updates

Slammed 27% XWELL, Inc. (NASDAQ:XWEL) Screens Well Here But There Might Be A Catch

Sep 06

XWELL, Inc. (NASDAQ:XWEL) Might Not Be As Mispriced As It Looks After Plunging 29%

Jul 14

It's Down 27% But XWELL, Inc. (NASDAQ:XWEL) Could Be Riskier Than It Looks

Apr 03

Further Upside For XWELL, Inc. (NASDAQ:XWEL) Shares Could Introduce Price Risks After 33% Bounce

Feb 15

These 4 Measures Indicate That XpresSpa Group (NASDAQ:XSPA) Is Using Debt Safely

May 10

Rock star Growth Puts XpresSpa Group (NASDAQ:XSPA) In A Position To Use Debt

Jan 11

XpresSpa Is A Strong Buy With Covid Testing Earnings Power

Dec 13

We Think The Compensation For XpresSpa Group, Inc.'s (NASDAQ:XSPA) CEO Looks About Right

Sep 24

Analysts Have Been Trimming Their XpresSpa Group, Inc. (NASDAQ:XSPA) Price Target After Its Latest Report

Aug 19

Is XpresSpa Group (NASDAQ:XSPA) Weighed On By Its Debt Load?

Jun 22

XpresSpa Group to be a part of Russell Microcap Index

Jun 09

XpresSpa launches a new travel brand 'Treat'

Jun 01

XpresSpa Group Stock Forecast: What To Think About After 2020 Q4 Earnings

May 04

XpresSpa Uniquely Positioned To Benefit As Airport COVID-19 Testing Gains Momentum

Feb 04

XpresSpa hits session highs as CEO set to appear on Fox Business

Jan 05

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $23.1M ) XWEL } overtreffen de korte termijn passiva ( $10.4M ).

Langlopende schulden: De kortetermijnactiva XWEL ( $23.1M ) overtreffen de langetermijnschulden ( $8.6M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: XWEL is schuldenvrij.

Schuld verminderen: XWEL heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 79% was.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: XWEL heeft op basis van de huidige vrije kasstroom voldoende kasstroom voor meer dan een jaar.

Voorspelling contante baan: Er wordt voorspeld dat XWEL voldoende kasmiddelen zal hebben voor 11 maanden op basis van de vrije kasstroom schattingen, maar heeft sindsdien extra kapitaal opgehaald.

XWELL Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

XWELL, Inc. announced delayed amended 10-K filing

XWELL, Inc. announced delayed annual 10-K filing

XWELL, Inc. Announces 1-for-20 Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

XWELL (NASDAQ:XWEL) Will Have To Spend Its Cash Wisely

XWELL, Inc. Receives Non-Compliance Letter from the Nasdaq

XpresSpa Group, Inc. Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

Recent updates

Slammed 27% XWELL, Inc. (NASDAQ:XWEL) Screens Well Here But There Might Be A Catch

XWELL, Inc. Announces Executive Changes

XWELL, Inc., Annual General Meeting, Sep 20, 2024

Second quarter 2024 earnings released: US$0.48 loss per share (vs US$1.37 loss in 2Q 2023)

CPC Decides to Withdraw Lawsuit Against XWELL

New minor risk - Shareholder dilution

XWELL, Inc. has completed a Follow-on Equity Offering in the amount of $1.422897 million.

New major risk - Share price stability

XWELL, Inc. has filed a Follow-on Equity Offering in the amount of $1.422897 million.

CPC Pain & Wellness SPV Files Complaint in the Delaware Court of Chancery Against XWELL

XWELL, Inc. (NASDAQ:XWEL) Might Not Be As Mispriced As It Looks After Plunging 29%

CPC Pain & Wellness SPV Engages in Discussions with XWELL

XWELL, Inc. Introduces New Esthetic Facial Services to Naples Wax Center Locations

XWELL, Inc. Plans to Introduce the Ceragem V6 Therapeutic Thermal Massager in Select Xpresspa Locations

XWELL, Inc. Introduces IV Hydration Drip Therapy at Miami International Airport

XWELL, Inc. to Report Fiscal Year 2023 Results on Apr 16, 2024

XWELL, Inc. announced delayed amended 10-K filing

XWELL, Inc. announced delayed annual 10-K filing

It's Down 27% But XWELL, Inc. (NASDAQ:XWEL) Could Be Riskier Than It Looks

Further Upside For XWELL, Inc. (NASDAQ:XWEL) Shares Could Introduce Price Risks After 33% Bounce

XWELL, Inc. Elects Gaëlle S. Wizenberg as Member of the Audit Committee and the Compensation Committee

Not Many Are Piling Into XWELL, Inc. (NASDAQ:XWEL) Stock Yet As It Plummets 29%

XWELL, Inc. Announces Board Changes, Effective January 1, 2024

XWELL, Inc. Introduces Clockwork Robotic Manicures At Harry Reid International Airport in Las Vegas

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

XWELL, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2023

XWELL, Inc. Announces 1-for-20 Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

XWELL, Inc. (NasdaqCM:XWEL) acquired Naples Wax Center, Inc.

Second quarter 2023 earnings: Revenues and EPS in line with analyst expectations

XWELL, Inc. to Report Q2, 2023 Results on Aug 14, 2023

XWELL, Inc., Annual General Meeting, Aug 22, 2023

Xpresspa Debuts Clockwork Robotic Manicures At Miami International Airport

New minor risk - Share price stability

XWELL (NASDAQ:XWEL) Will Have To Spend Its Cash Wisely

XWELL, Inc. Announces Executive Changes, Effective July 10, 2023

XWELL, Inc. to Report Q1, 2023 Results on May 15, 2023

XWELL, Inc. Names Valerie Lightfoot Chief Financial Officer

Consensus revenue estimates fall by 33%

Full year 2022 earnings: EPS misses analyst expectations

There's No Escaping XWELL, Inc.'s (NASDAQ:XWEL) Muted Revenues

Consensus EPS estimates fall by 12%

Consensus revenue estimates fall by 14%

Price target decreased to US$2.00

Third quarter 2022 earnings released: US$0.076 loss per share (vs US$0.053 profit in 3Q 2021)

Price target decreased to US$2.00

XWELL, Inc. Announces Impairment Charges for the Three Months Ended September 30, 2022

XWELL, Inc. to Report Q3, 2022 Results on Nov 10, 2022

XWELL, Inc. Receives Non-Compliance Letter from the Nasdaq

XpresSpa Group, Inc. Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

XpresSpa Group, Inc., Annual General Meeting, Oct 04, 2022

XpresSpa Group Announces the Re-Opening of XpresSpa™ Location At John F. Kennedy International Airport’s Terminal 4

XpresSpa Q2 2022 Earnings Preview

XpresSpa Group, Inc. to Report Q2, 2022 Results on Aug 15, 2022

XpresSpa Group Announces the Separation of Service of Chief Financial Officer James Berry

Consensus revenue estimates fall by 36%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

XpresSpa Group, Inc. Revises Revenue Guidance for the Year 2022

XpresSpa Group, Inc. to Report Q1, 2022 Results on May 16, 2022

These 4 Measures Indicate That XpresSpa Group (NASDAQ:XSPA) Is Using Debt Safely

Price target increased to US$4.00

Xpresspa Group, Inc. Announces Travel Health and Wellness Brand Treat™ Launches At Phoenix Sky Harbor International Airport

XpresSpa Group, Inc. Announces the Addition of Five New Xpresspa Locations in Istanbul

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

XpresSpa Group, Inc. Announces Resignation of Douglas Satzman as President

XpresSpa Group, Inc. (NasdaqCM:XSPA) entered into an acquisition agreement to acquire Gcg Connect Llc.

Rock star Growth Puts XpresSpa Group (NASDAQ:XSPA) In A Position To Use Debt

Independent Chairman of the Board recently bought US$64k worth of stock

XpresSpa Is A Strong Buy With Covid Testing Earnings Power